These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7141445)

  • 1. Growth inhibitors in plasma derived human serum.
    Pigott DA; Grimaldi MA; Dell'Aquila ML; Gaffney EV
    In Vitro; 1982 Jul; 18(7):617-25. PubMed ID: 7141445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of malignant mammary cell lines to a growth inhibitor partially purified from plasma-derived human serum.
    Dell'Aquila ML; Gaffney EV
    J Natl Cancer Inst; 1984 Aug; 73(2):397-403. PubMed ID: 6589431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
    Dell'Aquila ML; Pigott DA; Bonaquist DL; Gaffney EV
    J Natl Cancer Inst; 1984 Feb; 72(2):291-8. PubMed ID: 6582317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth of human breast cancer cell line MCF-7 by serum derived from calcium chloride-clotted plasma.
    Gaffney EV; Grimaldi MA; Pigott DA; Dell'Aquila M
    J Natl Cancer Inst; 1980 Dec; 65(6):1215-9. PubMed ID: 6933268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7.
    Laursen I; Briand P; Lykkesfeldt AE
    Anticancer Res; 1990; 10(2A):343-51. PubMed ID: 2346307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
    Johnston PG; Rondinone CM; Voeller D; Allegra CJ
    Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines.
    Sidi Y; Beery E; Panet C; Wasserman L; Novogrodsky A; Nordenberg J
    Eur J Cancer Clin Oncol; 1989 May; 25(5):883-9. PubMed ID: 2737221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell proliferation by interleukin-1 derived from monocytic leukemia cells.
    Tsai SC; Gaffney EV
    Cancer Res; 1986 Mar; 46(3):1471-7. PubMed ID: 3484681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and properties of growth inhibitor from normal rabbit serum.
    Kimura T; Miyazaki K; Mashima K; Yamashita J; Horio T; Kakuno T
    J Biochem; 1991 Sep; 110(3):423-8. PubMed ID: 1769970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification of a protein growth inhibitor from multicellular spheroids.
    Freyer JP; Schor PL; Saponara AG
    Biochem Biophys Res Commun; 1988 Apr; 152(1):463-8. PubMed ID: 3358771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a growth-inhibiting protein present in rat serum that exerts a differential effect on in vitro growth of nonmalignant rat liver cells when compared with Rous sarcoma virus-transformed rat liver cells.
    Miyazaki K; Mashima K; Yamashita N; Yamashita J; Horio T
    In Vitro Cell Dev Biol; 1985 Jan; 21(1):62-6. PubMed ID: 3003021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells.
    Ervin PR; Kaminski MS; Cody RL; Wicha MS
    Science; 1989 Jun; 244(4912):1585-7. PubMed ID: 2662405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma.
    Andress DL; Howard GA; Birnbaum RS
    Kidney Int; 1991 May; 39(5):942-5. PubMed ID: 2067211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum and the growth of human mammary cells.
    Gaffney EV; Pigott DA; Grimaldi MA
    J Natl Cancer Inst; 1979 Oct; 63(4):913-8. PubMed ID: 225502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small molecular weight growth inhibitory factor in tissue culture supernatants.
    Djerassi I
    J Med; 1983; 14(5-6):415-32. PubMed ID: 6583300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and partial characterization of two types of growth-inhibitory protein latently present in rabbit serum.
    Kimura T; Miyazaki K; Yamashita J; Horio T; Kakuno T
    Biochim Biophys Acta; 1992 Feb; 1118(3):239-48. PubMed ID: 1371074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective inhibitor of cell proliferation from normal serum.
    Harrington WN; Godman GC
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):423-7. PubMed ID: 6928635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of growth-inhibitory activity in serum-free medium by human monocytic leukemia cells.
    Gaffney EV; Tsai SC; Dell'Aquila ML; Lingenfelter SE
    Cancer Res; 1983 Aug; 43(8):3668-73. PubMed ID: 6344988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.
    Pagliacci MC; Smacchia M; Migliorati G; Grignani F; Riccardi C; Nicoletti I
    Eur J Cancer; 1994; 30A(11):1675-82. PubMed ID: 7833143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.